vaccin
biolog
agent
provid
activ
acquir
immun
particular
diseas
success
vaccin
one
costeffect
altern
control
incid
mortal
diseas
influenza
cholera
bubon
plagu
hepat
yellow
fever
measl
mump
rubella
tetanu
diphtheria
anim
diseas
etc
gener
exist
vaccin
divid
two
broad
group
live
nonliv
vaccin
vaccin
divid
four
categori
vaccin
contain
microorgan
artifici
inactiv
chemic
heat
ii
vaccin
contain
microorgan
undergon
attenu
cultur
directli
use
relev
immunolog
substanc
iii
vaccin
deriv
inactiv
toxic
compound
rather
microorgan
refer
toxoidbas
vaccin
iv
subunit
vaccin
use
purifi
fragment
pathogen
abl
creat
immun
respons
moreov
quantiti
innov
bacteri
vaccin
also
develop
use
past
two
decad
promis
dna
vaccin
technolog
offer
simplic
prepar
rapid
rel
inexpens
mass
product
becom
altern
tradit
vaccin
continu
evolv
dna
vaccin
use
treat
human
anim
infect
cancer
allergi
autoimmun
diseas
antigen
structur
dna
vaccin
produc
vivo
similar
produc
natur
infect
induc
highli
specif
humor
cellular
respons
vaccin
primari
public
health
intervent
provid
protect
variou
infecti
diseas
human
immunodefici
hiv
infect
progress
slow
antiretrovir
therapi
erad
caus
approxim
one
million
death
year
use
success
vaccin
effect
control
infect
infecti
diseas
research
tri
use
vaccin
rather
chemic
materi
radiat
surgeri
fight
cancer
made
breakthrough
matej
et
al
found
clinic
trial
vaccin
glioblastoma
patient
exhibit
significantli
prolong
median
surviv
immun
addit
fibrosarcoma
local
aggress
malign
tumor
gener
treat
fibrosarcoma
requir
wide
excision
surgeri
although
often
difficult
remov
enough
incis
tumor
infiltr
site
katsuro
et
al
show
util
recombin
newcastl
diseas
viru
candid
tumor
therapi
due
specif
immun
purpos
effect
vaccin
three
key
factor
consid
antigen
immunopotenti
deliveri
system
antigen
play
role
trigger
adapt
immun
respons
activ
human
immun
respons
immunopotenti
act
enhanc
immunogen
stabil
antigen
promot
synthesi
secret
antibodi
deliveri
system
essenti
transport
medium
make
sure
antigen
target
antigenpres
cell
apc
emerg
multipl
type
vaccin
deliveri
vaccin
also
present
varieti
situat
research
commit
design
multifari
target
deliveri
system
purpos
make
best
use
vaccin
exampl
nanoparticl
np
serv
stabil
vaccin
antigen
vaccin
adjuv
viruslik
particl
liposom
colloid
saponin
contain
micel
iscom
polym
nondegrad
nanospher
note
deliveri
vector
abil
activ
differ
element
immun
system
well
good
biocompat
np
enter
apc
differ
rout
therebi
modul
immun
respons
antigen
addit
natur
also
provid
substanc
gift
vaccin
deliveri
chitosan
obtain
deacetyl
chitin
wide
present
natur
figur
slightli
pearlesc
transluc
flaki
white
solid
basic
properti
chitosan
insolubl
water
alkalin
solut
solubl
dilut
acid
form
sticki
solut
howev
dilut
acid
glycosid
bond
chitosan
hydrolyz
slowli
result
gradual
decreas
viscos
chitosan
contain
hydroxyl
amino
polar
group
show
good
hygroscop
moistur
retent
chitosan
use
drug
carrier
degrad
nontox
substanc
lysozym
releas
drug
slowli
well
properti
form
film
chitosan
adsorb
protein
amino
acid
nucleic
acid
substanc
complex
ion
exchang
worth
noth
chitosan
deriv
good
biocompat
biodegrad
degrad
product
toxic
side
effect
immunogen
accumul
also
mani
uniqu
properti
antibacteri
antimicrobi
diseas
resist
anticanc
wound
heal
therefor
appli
broadli
pharmaceut
industri
compar
convent
excipi
due
excel
properti
moreov
safeti
chitosan
well
mucos
adsorptionpromot
properti
allow
develop
vaccin
deliveri
year
research
design
variou
vaccin
deliveri
system
base
chitosan
improv
drawback
chitosan
modif
maxim
effect
review
summar
commonli
use
vaccin
deliveri
system
base
chitosan
provid
overview
specif
modif
chitosan
vaccin
deliveri
detail
introduc
variou
improv
program
chitosan
chemic
modif
hydrophil
modif
hydrophob
modif
specif
ligand
modif
galactos
mannos
peptid
mcell
target
modif
dna
vaccin
applic
modifi
chitosan
present
recommend
research
result
applic
final
offer
view
studi
applic
prospect
chitosan
wide
use
excel
biocompat
strong
mucoadhes
properti
mucos
drug
deliveri
howev
instabl
chitosan
microparticl
cmp
make
chitosan
mp
easili
aggreg
among
variou
watersolubl
polym
peg
chosen
modifi
chitosan
due
protein
resist
low
toxic
overcom
instabl
chitosan
jiang
et
al
design
synthes
pegyl
chitosan
mp
pcmp
use
peg
watersolubl
polym
figur
pcmp
load
bordetella
bronchiseptica
dermonecrotoxin
bbd
averag
particl
size
show
high
bbd
load
rate
stabl
cmp
load
bbd
suggest
bbdload
pcmp
could
promis
candid
bbd
vaccin
deliveri
glycol
due
strong
hydrophil
properti
often
use
modifi
hydrophob
chemic
improv
water
solubl
chitosan
deriv
glycol
chitosan
gc
possess
low
toxic
high
biocompat
biodegrad
mucoadhes
properti
permeat
enhanc
effect
gc
prepar
reaction
chitosan
chloroethanol
figur
improv
water
solubl
chitosan
bestatin
conjug
gc
thymopoietin
oligopeptid
deliveri
conjug
bestatin
gc
affect
specif
interact
bestatin
aminopeptidas
remark
protect
thymopoietin
oligopeptid
enzymat
degrad
attract
excel
perform
gc
pawar
et
al
prepar
chitosan
gccoat
plga
nanoparticl
np
cplga
gcplga
result
verifi
coat
chitosan
chang
immun
respons
plga
np
gcplga
np
show
better
local
system
uptak
elicit
stronger
immun
respons
compar
cplga
indic
better
immun
respons
cplga
np
glycol
addit
feng
et
al
conjug
ethylen
diamin
tetraacet
acid
edta
gc
remark
inhibit
leucin
aminopeptidasemedi
degrad
thymopoietin
oligopeptid
furthermor
lee
et
al
use
coreshel
polymer
np
compos
hydrophob
plga
core
positivelycharg
gc
transderm
deliveri
dna
epiderm
langerhan
cell
lc
result
show
np
transfect
dna
directli
lc
present
epidermi
transfect
lc
migrat
express
encod
gene
product
skin
drain
lymph
node
indic
potenti
usag
immunotherapi
vaccin
develop
addit
gc
np
confirm
great
potenti
mucos
administr
vaccin
poloxam
copolym
poli
oxyethylen
poli
oxypropylen
poli
oxyethylen
peoppopeo
possess
good
drug
load
capac
watersolubl
toler
nontox
control
releas
abil
due
solgel
transit
among
block
copolym
also
known
poloxam
figur
nonion
hydrophil
triblock
copolym
use
protein
stabil
immunomodul
improv
instabl
vaccin
protein
increas
adjuvant
vitro
experi
result
demonstr
bordetella
bronchiseptica
dermonecrotoxin
bbd
load
cmp
prepar
presenc
show
significantli
higher
immunestimul
activ
chitosan
mp
suggest
addit
enhanc
stabil
use
vaccin
uptak
bbdload
cm
immun
cell
chitosan
effici
nontox
absorpt
enhanc
oral
nasal
administ
peptidebas
vaccin
howev
chitosan
proton
form
watersolubl
acid
environ
due
pka
valu
around
recent
attent
research
attract
trimethyl
chitosan
figur
excel
water
solubl
wide
ph
rang
subbiah
et
al
load
hepat
b
viru
surfac
antigen
hbsag
n
n
ntrimethyl
chitosan
nanoparticl
tmc
np
control
intranas
deliveri
figur
releas
hbsag
antigen
hbsagload
tmc
np
reach
prolong
period
day
vivo
addit
vivo
immunolog
studi
reveal
adjuv
effici
hbsagload
tmc
np
highli
stabl
long
time
better
control
suggest
tmc
np
use
wide
treatment
variou
diseas
control
intranas
deliveri
lu
et
al
investig
effect
tmc
mp
drug
releas
rate
transport
across
intestin
epitheli
cell
result
show
releas
drug
drugload
tmc
mp
interact
intestin
epitheli
cell
affect
permeat
releas
drug
maaden
et
al
coat
inactiv
polio
vaccin
ipv
particl
tmc
via
electrostat
interact
use
phsensit
microneedl
array
coat
tmc
producesd
suffici
high
antigen
dose
addit
result
show
method
use
approach
microneedlebas
vaccin
addit
methyl
n
ndimethylaminobenzyl
chitosan
tmbc
methyl
n
ndimethylaminocinnamyl
chitosan
tmcc
methyl
n
chitosan
tmpc
also
prepar
deliv
ovalbumin
ova
oral
vaccin
result
indic
tmcc
show
effici
immun
respons
ovaload
mp
coat
tmcc
electrospray
exhibit
highest
vivo
adjuv
activ
igg
iga
immunogen
oral
vaccin
furthermor
phrespons
plga
chitosanmodifi
plga
csplga
mannanmodifi
plga
mnplga
mannan
chitosan
comodifi
plga
mncsplga
use
deliv
hepat
b
surfac
antigen
hbsag
via
nasal
administr
result
indic
mncsplga
mp
induc
stronger
humor
cellmedi
immun
respons
due
specif
interact
mannos
receptor
antigenpres
cell
apc
compar
other
folic
acid
fa
appeal
ligand
target
cell
membran
allow
nanoparticl
endocytosi
via
folat
receptor
fr
higher
transfect
yield
mansouri
et
al
first
describ
technic
detail
fac
prepar
figur
sinc
fa
commonli
use
modifi
chitosan
due
overexpress
folat
receptor
cancer
cell
surfac
hu
et
al
util
fac
np
make
polym
complex
mous
interferoninduc
gene
combin
dendrit
cell
dc
tumor
cell
fusion
vaccin
battl
hepatocellular
carcinoma
hcc
shown
figur
combin
therapi
significantli
increas
tumorspecif
respons
reduc
myeloidderiv
suppressor
cell
mdsc
mous
local
tumor
spleen
bone
marrow
furthermor
combin
therapi
effect
inhibit
prolifer
growth
tumor
cell
prolong
overal
surviv
mice
mannos
receptor
highli
express
dendrit
cell
macrophag
play
vital
role
immun
respons
thu
polym
mannosyl
effici
bind
macrophag
via
specif
interact
mannos
receptor
result
enhanc
cellular
uptak
promot
antigen
present
cell
activ
current
mannosyl
wide
appli
modif
drug
deliveri
system
augment
immunogen
jiang
et
al
prepar
mannosyl
chitosan
microspher
mcm
figur
encapsul
bordetella
bronchiseptica
antigen
contain
dermonecrotoxin
bbd
vaccin
deliveri
platform
bind
abil
bbdmcm
murin
macrophag
raw
cell
surfac
mannos
receptor
overexpress
confirm
fluoresc
confoc
microscopi
vivo
experi
reveal
much
higher
bbdspecif
iga
antibodi
respons
induc
bbdmcm
induc
bbdload
cm
saliva
serum
figur
impli
signific
impact
mannos
moieti
enhanc
immunestimul
activ
via
specif
interact
mannos
group
mannos
receptor
addit
glucomannosyl
chitosan
nanoparticl
gmcnp
develop
deliv
tetanu
toxoid
tt
use
tandem
crosslink
method
develop
hard
et
al
obtain
gmcnp
act
vaccin
carrier
immunopotenti
tt
help
clathrin
receptormedi
endocytosi
higher
intracellular
uptak
realiz
gmcnp
raw
cell
cell
compar
control
gmcnp
elicit
significantli
higher
mucos
humor
cellular
immun
respons
difficult
achiev
simultan
commerci
tt
vaccin
addit
yao
et
al
util
mc
condens
antigrp
dna
vaccin
pgrp
subcutan
prostat
carcinoma
model
establish
evalu
vivo
efficaci
result
show
level
antigrp
igg
mice
treat
mcpgrp
significantli
higher
treat
cpgrp
np
p
moreov
growth
tumor
cell
suppress
via
immun
mcpgrp
np
cell
dispers
among
epitheli
cell
found
variou
mucosaassoci
lymphoid
tissu
malt
nasalassoci
lymphoid
tissu
nalt
gutassoci
lymphoid
tissu
galt
bronchusassoci
lymphoid
tissu
balt
although
cell
galt
import
play
key
role
regul
gastrointestin
gi
tract
infect
immun
mcell
galt
locat
follicleassoci
epithelium
fae
lie
peyer
patch
ileum
jejunum
small
intestin
also
uptak
deliv
antigen
across
mucos
epithelia
underli
lymphoid
tissu
gener
protect
immun
respons
transcytosi
interestingli
proport
cell
fae
speciesdepend
percentag
cell
total
cell
fae
rabbit
rodent
human
around
respect
report
origin
stem
cell
crypt
locat
villu
peyer
patch
dome
although
origin
cell
still
controversi
peptid
seen
attract
specif
ligand
easili
synthes
chemic
method
larg
scale
peptid
ligand
cell
receptor
accumul
coat
pit
receptorligand
specif
interact
gener
two
kind
method
screen
peptid
ligand
chemic
synthesi
phage
display
yoo
et
al
screen
celltarget
ninepeptid
ligand
cksthplsc
phage
display
techniqu
confirm
target
specif
vitro
transcytosi
assay
vivo
assay
conjug
watersolubl
chitosan
figur
chitosan
nanoparticl
prepar
ionic
gelat
accumul
peyer
patch
region
greater
amount
chitosan
nanoparticl
figur
suggest
effect
vaccin
carrier
also
conjug
chitosan
coat
porou
plga
microparticl
deliv
brachyspira
hyodysenteria
bmpb
swine
dysenteri
vaccin
porou
surfac
intern
morpholog
bmpbplga
bmpbwscplga
mp
observ
spheric
shape
figur
also
found
oral
immun
bmpbload
plga
microparticl
coat
chitosan
mice
show
elev
secretori
iga
respons
mucos
tissu
system
igg
antibodi
respons
figur
owe
mcell
target
transcytosi
abil
chitosanco
plga
microparticl
figur
similarli
ye
et
al
conjug
c
termin
amino
acid
clostridium
perfringen
enterotoxin
peptid
mcell
target
ligand
chitosan
deliv
coxsackieviru
predomin
dna
vaccin
mice
oral
immun
cpe
dna
vaccin
nanoparticl
significantli
increas
specif
fecal
siga
level
augment
mucos
tcell
immun
respons
myocard
due
mcell
target
abil
cpe
lectin
natur
origin
protein
high
affin
carbohydr
residu
present
cell
surfac
protein
lipid
moststudi
lectin
ulex
europaeu
lectin
use
specif
ligand
target
deliveri
mcell
bind
residu
express
apic
surfac
mous
mcell
malik
et
al
prepar
alginateco
chitosan
np
ionic
gelat
deliv
bovin
serum
albumin
bsa
model
vaccin
balbc
mice
figur
oral
immun
bsaload
alginateco
chitosan
np
induc
mucos
immun
respons
compar
aluminum
hydroxid
gelbas
convent
vaccin
although
mcell
target
use
mainli
restrict
mous
model
target
present
human
mcell
similarli
kallr
et
al
conjug
wheat
germ
agglutinin
wga
anoth
lectin
chitosan
microspher
cm
load
reduc
bromin
deriv
noscapin
redbrno
increas
antiinflammatori
respons
dextran
sodium
sulfat
dss
induc
coliti
model
mice
result
indic
surfac
bioadhes
properti
wgaconjug
cm
load
redbrno
promot
affin
toward
colon
mucin
cell
simul
colon
fluid
scf
ph
cm
load
redbrno
wgaconjug
cm
load
redbrno
remark
attenu
dss
encourag
neutrophil
infiltr
proinflammatori
cytokin
product
mice
compar
cm
load
redbrno
although
clear
whether
increas
cytokin
product
cm
uptak
induc
wga
attribut
mcell
wga
specif
mous
mcell
induct
immun
respons
administr
dna
vaccin
provid
altern
type
vaccin
dna
vaccineencod
protein
mimic
antigen
express
viral
infect
henc
possess
advantag
safeti
live
attenu
vaccin
improv
activ
immun
system
xu
et
al
prepar
chitosandna
vaccin
complex
induc
specif
immun
respons
via
intranas
administr
shown
figur
immun
chitosandna
encod
mice
much
higher
level
mucos
secretori
iga
serum
igg
produc
compar
group
immun
addit
percent
mice
treat
protect
lethal
challeng
viral
load
happen
acut
infect
also
significantli
reduc
zhou
et
al
develop
novel
approach
deliv
hbv
dna
vaccin
effici
apc
via
peidna
complex
entrap
mc
microspher
compar
nake
dna
enhanc
antibodi
respons
realiz
mc
microspher
dose
time
point
evalu
addit
time
requir
detect
antibodi
respons
follow
immun
shorten
two
week
mc
microspher
similarli
purpos
provid
pdna
vaccin
adjuvantequip
carrier
system
heuk
et
al
modifi
chitosan
tolllik
receptor
agonist
moieti
via
peg
linker
result
show
agonistmodifi
chitosan
significantli
increas
immun
stimulatori
abil
human
macrophag
compar
control
chitosan
np
use
dna
vaccin
carrier
due
excel
capac
enhanc
mucosa
absorpt
stabil
howev
dna
degrad
gut
hamper
develop
oral
dna
vaccin
algin
natur
linear
unbranch
polysaccharid
compos
copolym
acid
acid
residu
use
oral
deliveri
dna
vaccin
due
stabil
ph
simul
gastric
fluid
liu
et
al
design
oral
deliveri
legumain
dna
vaccin
use
alginateco
chitosan
nanoparticl
ac
np
shown
figur
result
show
ac
np
aggreg
micromet
size
form
complex
dna
vaccin
ph
dispers
nanoparticl
increas
ph
figur
indic
degre
ph
depend
complex
ac
np
also
use
inhibit
tumor
orthotop
breast
cancer
model
found
complex
show
excel
tumor
inhibit
figur
studi
suggest
algin
acidco
chitosan
np
effici
safe
carrier
oral
deliveri
dna
vaccin
chitosan
deriv
hold
enorm
promis
adjuv
deliveri
vehicl
especi
form
micro
nanoparticul
review
explor
evalu
variou
modif
chitosan
could
help
deliv
vaccin
effici
apc
turn
could
induc
higher
immun
respons
furthermor
function
modif
multipl
properti
chitosan
substanti
improv
increas
stabil
membran
permeabl
mucoadhes
control
releas
behavior
reveal
promis
vaccin
carrier
system
specif
ligand
like
mannos
conjug
chitosan
deriv
specif
interact
desir
cell
type
achiev
target
vaccin
deliveri
despit
advantag
mani
challeng
irregular
distribut
low
physic
stabil
still
hinder
commerci
chitosan
care
solv
futur
applic
nevertheless
chitosan
deriv
enough
potenti
encourag
research
continu
investig
field
vaccin
deliveri
